FARYDAK panobinostat 10 mg Capsules


Facts of FARYDAK panobinostat 10 mg Capsules?

  • Medicine Name: FARYDAK
  • Generic Name: panobinostat
  • Approval Date: February 23, 2015
  • Company Name: Novartis Pharmaceuticals Corporation
  • Available as (Form & Strength): 10 mg, 15 mg, and 20 mg Capsule for Oral Use

What are the indications and usage?

  • FARYDAK panobinostat is a prescription medicine used, in combination with bortezomib and dexamethasone, to treat people with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.